The Global BloodDialyzer Market, by Product Type (Reusable and Disposable), by DialysisMembrane Material (Cellulose Membranes and Synthetic Membranes), by End User(Hospitals, Ambulatory Surgical Centers, Home Care Settings, and SpecialtyClinics), was valued at US$ 4,682.7 million in 2017, and is projected toexhibit a CAGR of 6.1%, during the forecast period (2018 - 2026).
Dialysis is a treatment done onpatients at later stage of kidney failure (chronic renal insufficiency). Thistreatment is achieved by using an assembly called dialyzers, which cleans bloodand removes wastes and excess fluid from the body that are normally removed byhealthy kidneys. In hemodialysis, blood is removed from the body and circulatedthrough an extracorporeal fluid circuit (outside the body), then returned tothe body. Hemodialyzer encloses a selectively permeable membrane acting as afilter that allows fluids and waste materials to pass through. Increasing incidenceof chronic kidney diseases is expected to increase the number of dialysisprocess, which in turn will fuel growth of the blood dialyzers market duringthe forecast period. For instance, according to the Global Kidney Health AtlasApril 2017, one in three people in the general population is at increased riskof chronic kidney diseases and an estimated 10% of people worldwide, hadchronic kidney disease (CKD) in 2017. Furthermore, the estimates suggest that 9in 10 of those suffering from CKD are unacquainted of their condition.
Browse 23 Market Data Tables and19 Figures spread through 157 Pages and in-depth TOC on "Blood DialyzerMarket, by Product Type (Reusable, and Disposable), by Dialysis MembraneMaterial (Cellulose Membranes, and Synthetic Membranes), by End User(Hospitals, Ambulatory Surgical Centers, Home Care Settings, and SpecialtyClinics) - Global Forecast to 2026"
* The sample copy includes:Report Summary, Table of Contents, Segmentation, Competitive Landscape, ReportStructure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2503
Manufacturers are engaged inintensifying its services by expanding manufacturing units, and joint ventures.For instance, in December 2017, Nikkiso Co. Ltd. of Japan partnered with Chinabased, Shandong Weigao Group Medical Polymer Company, to increase production ofdialyzers in China by fivefold by 2020, and raise its output to 20,000 unitsevery year. Furthermore, key players are focusing on new product launches tomaximize access to end users for its products and in turn increase its marketshare. For instance, in September 2016, B. Braun Medical Inc., launched xevontakidney dialyzer, following 501(k) clearance by the FDA. This dialyzer will beavailable in the U.S. market. Xevonta kidney dialyzer's innovative membranetechnology was intended to improve clearance performance by removing moretoxins from patients’ blood. Also, in May 2017, NxStage Medical, Inc. receivedclearance from FDA for the next generation hemodialysis system. It consists ofnew features and capabilities, including a touchscreen user interface andintegrated blood pressure monitor designed to enhance ease of use for patientsto perform home hemodialysis. Moreover, rising government initiatives toadvance improved treatment options for patients with kidney failure aidsmanufacturers to gain substantial growth in the global blood dialyzer market.
For instance, in September 2018,the U.S. Department of Health and Human Services (HHS) and the American Societyof Nephrology (ASN) held a prize money of US $ 2,265,000 for KidneyX: RedesignDialysis. This competition challenges manufacturers to develop better treatmentoptions for patients with kidney failure. Thus, HHS is expecting innovations inthe field of dialysis and dialyzer membranes to redesign treatment for kidneyfailure.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/blood-dialyzer-market-2503
Key Takeaways of the BloodDialyzer Market:
The global blood dialyzer marketis expected to expand at a CAGR of 6.1% during the forecast period (2018 –2026), owing to continuous technological advancements in dialyzers membrane.
Based on product type, disposabledialyzers are expected to receive maximum growth, owing to risks associatedwith reusable dialyzers.
On the basis of dialysis membranematerial, synthetic cellulose segment is expected to perceive maximum tractionowing to new product launches. For instance, in November 2017, Nipro MedicalCorporation announced the launch of Cellentia-H cellulose triacetate (CTA), asingle-use dialyzer at the 2017 ASN Kidney Week Conference. The cellulosetriacetate membrane optimizes excellent biocompatibility and clearances tominimize potential adverse reactions. The Cellentia-H is also gamma sterilizedto enhance product safety and sterility. Such technology advancements in blooddialyzers promote its growth in the global market during the forecast period.
Major players operating in theglobal blood dialyzer market include Baxter International, Inc., Nikkiso Co.Ltd., B. Braun Medical Inc., Nipro Corporation, CVS Health., DiaverumDeutschland GmbH, NxStage Medical, Inc., Fresenius Medical Care AG & Co.KGaA, and DaVita Healthcare Partners, Inc.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2503
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
